Minute Molecular Diagnostics, a spinoff company in which Northwestern has equity and royalties, is commercializing the test and will use the NIH grant to start making a million of the test cartridges each month, according to the university. However, distribution still requires an emergency use authorization through the U.S. Food and Drug Administration.
Coronavirus in Illinois updates: Here’s what’s happening Tuesday with COVID-19 in the Chicago area
